Delivery Order SPE2DB20D2104-SPE2DB25FMXLH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,385.11 to AmerisourceBergen Drug Corp for 1,000 tablets of Premarin 0.3 mg, a hormone replacement therapy medication. This non-set-aside contract was competitively awarded with a firm fixed price structure and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at approximately $30,080 to AmerisourceBergen Drug Corp for 1,000 tablets of Premarin 0.3 mg, a hormone replacement therapy medication. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $15,612.00 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. This competitively awarded, firm fixed-price contract includes performance at AmerisourceBergen's Conshohocken, Pennsylvania facility with an ultimate completion date of August 1, 2025. The delivery order carries no set-aside designation, reflecting the company's demonstrated capability to compete openly for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,808.85 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Premarin, a hormone replacement therapy medication, falls within the...
- The Defense Logistics Agency awarded a delivery order valued at $11,614.48 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price contract involves no set-aside designation and represents a competitive award to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of 1,000 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. This $2,621.00 firm fixed-price delivery order, with performance in Park Ridge, Illinois, represents a non-competitive award under an existing contract vehicle. The delivery is scheduled for completion by August 11, 2025. This delivery order falls under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,609.28 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg on July 24, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by July 25, 2025, with work to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Premarin is a conjugated estrogen hormone replacement therapy...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Premarin 0.625 mg tablets (100-count units) with a contract ceiling value of $1,490.37. This firm fixed-price delivery order, which is expected to be completed by August 4, 2025, represents a non-competitive set-aside arrangement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,600.44 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.625 mg on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award is issued under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,436.56 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100 count) on July 28, 2025. This firm fixed-price delivery order, designated as contract 4568902309, is scheduled for completion by July 29, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation and represents a routine pharmaceutical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXLHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,654.18 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. The contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including critical medications, vaccines, syringes, vials, and medical test kits across multiple therapeutic domains. The arrangement reflects DLA's strategy to maintain flexible pharmaceutical support through prime vendor relationships that serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/11/25 |